M. Santala et al., Elevated serum inhibin and tumor-associated trypsin inhibitor concentrations in a young woman with dysgerminoma of the ovary, GYNECOL ONC, 71(3), 1998, pp. 465-468
We describe a patient with dysgerminoma who had elevated serum inhibin, tum
or-associated trypsin inhibitor (TATI), and CA 125 concentrations, which in
creased progressively during follow-up of the advancing disease. Inhibin le
vels correlated closely with disease behavior. In contrast to inhibin, seru
m TATI and CA 125 failed to reveal the presence of silent disease. (C) 1998
Academic Press.